Membership in the society is open to researchers in the field of celiac disease and gluten sensitivity in the U.S., Canada and Mexico. The group has scheduled its first general assembly for May 20 in San Diego.
"The NASSCD’s overall mission is to advance the fields of celiac disease and gluten-related disorders by fostering research, and by promoting excellence in clinical care, including diagnosis and treatment of patients with these conditions," it said in a press release.
Dr. Stefano Guandalini, founder and medical director of the University of Chicago's Celiac Disease Center, was elected as the NASSCD’s first president. I met Guandalini at the Gluten Intolerance Group's conference in Orlando last year, and he is recognized as a leader in celiac research.
Research into celiac disease is growing, and the formation of this organization is a positive development. I'm very hopeful that within the next decade, we're going to see some form of medication that will allow celiacs to eat anything they want.
You can find more information the group at http://www.nasscd.org/